argenx(ARGX) - 2025 Q4 - Earnings Call Transcript

argenx (NasdaqGS:ARGX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAkash Tewari - Global Head of Biopharmaceutical ResearchAlex Thompson - Managing DirectorBeth DelGiacco - VP of Corporate AffairsDanielle Brill - Managing DirectorDouglas Tsao - Managing DirectorJames Gordon - Director and Head of European PharmaJustin Smith - DirectorKaren Massey - COOKarl Gubitz - CFOLuc Truyen - Chief Medical OfficerMatt Phipps - Partner and Group Head of BiotechnologyRajan Sharma - Executive D ...